ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
7
views
0
references
Top references
cited by
1
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,370
similar
All similar
Record
: found
Abstract
: not found
Book
: not found
Anticoagulants, Antiplatelets, and Thrombolytics
other
Editor(s):
Shaker A. Mousa
Publication date
(Print):
2010
Publisher:
Humana Press
Read this book at
Publisher
Further versions
oa repository (via OAI-PMH title match)
Powered by
Buy book
Review
Review book
Invite someone to review
Bookmark
Cite as...
There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
ScienceOpen Research
Author and book information
Book
ISBN (Print):
978-1-60761-802-7
ISBN (Electronic):
978-1-60761-803-4
Publication date (Print):
2010
DOI:
10.1007/978-1-60761-803-4
SO-VID:
9044a2ca-fa7b-4a61-aab1-fedf18e377bd
License:
http://www.springer.com/tdm
History
Data availability:
Comments
Comment on this book
Sign in to comment
Book chapters
pp. 1
In Vitro Methods of Evaluating Antithrombotics and Thrombolytics
pp. 29
In Vivo Models for the Evaluation of Antithrombotics and Thrombolytics
pp. 109
Heparin and Low-Molecular Weight Heparins in Thrombosis and Beyond
pp. 133
Laboratory Methods and Management of Patients with Heparin-Induced Thrombocytopenia
pp. 157
Novel Anticoagulant Therapy: Principle and Practice
pp. 181
Oral Direct Factor Xa Inhibitors, with Special Emphasis on Rivaroxaban
pp. 203
Antiplatelet Therapies: Drug Interactions in the Management of Vascular Disorders
pp. 221
Prasugrel: A Novel Platelet ADP P2Y12 Receptor Antagonist
pp. 229
Antithrombotic Effects of Naturally Derived Products on Coagulation and Platelet Function
pp. 241
Assessment of Anti-Metastatic Effects of Anticoagulant and Antiplatelet Agents Using Animal Models of Experimental Lung Metastasis
pp. 261
Adhesion Molecules: Potential Therapeutic and Diagnostic Implications
pp. 277
Pharmacogenomics in Thrombosis
pp. 291
Diagnosis and Management of Sickle Cell Disorders
Similar content
1,370
Erratum to: Antiplatelet therapy with CABG: chaos in the Netherlands
Authors:
F. Verheugt
Challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery
Authors:
Grace Wangge
,
Olaf H. Klungel
,
Kit Roes
…
A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
Authors:
Maria P. Wong
,
Scott Waldman
,
K M Gottesdiener
…
See all similar
Cited by
1
Recombinant Heparin—New Opportunities
Authors:
Charles Glass
See all cited by